Fergusson D - Search Results

1

Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.

Fergusson D, Hutton B, Sharma M, Tinmouth A, Wilson K, Cameron DW, Hebert PC. Fergusson D, et al. Transfusion. 2005 Oct;45(10):1640-57. doi: 10.1111/j.1537-2995.2005.00581.x. Transfusion. 2005. PMID: 16181216 Review.

2

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

Fergusson D, Hébert PC, Barrington KJ, Shapiro SH. Fergusson D, et al. Transfusion. 2002 Feb;42(2):159-65. doi: 10.1046/j.1537-2995.2002.00022.x. Transfusion. 2002. PMID: 11896329

3

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis.

Fergusson D, Aaron SD, Guyatt G, Hébert P. Fergusson D, et al. BMJ. 2002 Sep 21;325(7365):652-4. doi: 10.1136/bmj.325.7365.652. BMJ. 2002. PMID: 12242181 Free PMC article. Review. No abstract available.

4

The before/after study design in transfusion medicine: methodologic considerations.

Fergusson D, Hebert P, Shapiro S. Fergusson D, et al. Transfus Med Rev. 2002 Oct;16(4):296-303. doi: 10.1053/tmrv.2002.35211. Transfus Med Rev. 2002. PMID: 12415515

5

The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature.

Wilson K, MacDougall L, Fergusson D, Graham I, Tinmouth A, Hébert PC. Wilson K, et al. Among authors: fergusson d. Transfusion. 2002 Sep;42(9):1224-9. doi: 10.1046/j.1537-2995.2002.00185.x. Transfusion. 2002. PMID: 12430683 Review. No abstract available.

6

Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.

Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD; Leukoreduction Study Investigators. Hébert PC, et al. Among authors: fergusson d. JAMA. 2003 Apr 16;289(15):1941-9. doi: 10.1001/jama.289.15.1941. JAMA. 2003. PMID: 12697796

7

Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants.

Fergusson D, Hébert PC, Lee SK, Walker CR, Barrington KJ, Joseph L, Blajchman MA, Shapiro S. Fergusson D, et al. JAMA. 2003 Apr 16;289(15):1950-6. doi: 10.1001/jama.289.15.1950. JAMA. 2003. PMID: 12697797

8

How should Canada fund the blood system? An evaluation of the chargeback proposal.

Wilson K, MacDougall L, Pinard B, Amin MA, Fergusson D, Graham I, Blajchman M, Freedman J, Angus D, Hébert PC. Wilson K, et al. Among authors: fergusson d. Hosp Q. 2003 Spring;6(3):47-4. doi: 10.12927/hcq..16635. Hosp Q. 2003. PMID: 12846144

9

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Fergusson D, Glass KC, Waring D, Shapiro S. Fergusson D, et al. BMJ. 2004 Feb 21;328(7437):432. doi: 10.1136/bmj.37952.631667.EE. Epub 2004 Jan 22. BMJ. 2004. PMID: 14761905 Free PMC article. Review.

10

Consensus conference on vCJD screening of blood donors: report of the panel.

McCullough J, Anderson D, Brookie D, Bouchard JP, Fergusson D, Joly J, Kenny N, Lee D, Megânn H, Page D, Reinharz D, Williams JR, Wilson K. McCullough J, et al. Among authors: fergusson d. Transfusion. 2004 May;44(5):675-83. doi: 10.1111/j.1537-2995.2004.03310.x. Transfusion. 2004. PMID: 15104647 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,192 results

Search Page

Filters